top of page
Case Studies & Blogs
The Fast Lane to Evidence? What the New EMA Report Means for Trial Emulation
The European Medicines Agency (EMA) just released its third annual report on real-world evidence (RWE) in regulatory decision-making and...
Jul 8, 20253 min read
The Trouble with Comparators: Fixing External Control Arms with Trial Emulation
Real-world evidence is becoming central to regulatory and HTA decision-making in rare diseases and it is so for good reason. In many rare...
Jul 1, 20253 min read
When Real-World Evidence Gets Real: Lessons from the Frontlines of Target Trial Emulation
It’s not every day that three leaders in epidemiology, health technology assessment, and regulatory science gather to discuss what might...
Jun 19, 20253 min read
bottom of page